All Invokana lawsuits awaiting trial in the Federal court system will be centralized in multidistrict litigation (MDL), the U.S. Judicial Panel on Multidistrict Litigation (JPML) said recently. The MDL will be heard before a New Jersey U.S. District Judge, Brian Martinotti. The move concerns only... Read More

As more plaintiffs continue to file lawsuits against the manufacturer of the diabetes drug Invokana, a request has now been made to coordinate the proceedings into a central court. All of the lawsuits filed thus far are alleging serious injuries after taking Invokana, including heart... Read More

A new class of diabetes drugs known as SGLT2 inhibitors has been associated with an increased risk of ketoacidosis, according to a May 2015 safety alert from the FDA. Medications marketed under the brand names Farxiga, Xigduo XR, Invokana and Invokamet were the topic of... Read More

On February 12, the European Medicines Agency issued a new set of recommendations to minimize the risk of diabetic ketoacidosis in patients taking SGLT2 inhibitors — including Invokana. SGLT2 inhibitors are a type of type 2 diabetes medication designed to help lower blood sugar in... Read More

A plaintiff in Alabama has filed an Invokana complaint over the life-threatening condition she contends that the drug caused her to experience. Luana Jean Collie filed her complaint in the United States District Court, Southern District of Alabama, Southern Division on December 15, 2015. Collie’s... Read More

As patients with type 2 diabetes are increasingly prescribed drugs known as SGLT2 inhibitors to treat their illness, adverse event reports associated with the drugs are on the rise, according to a recent publication by a consumer watchdog group. The Institute for Safe Medication Practices... Read More

In late October, an Illinois man sued Invokana manufacturers Jannsen Pharmaceuticals, Inc., Johnson & Johnson Co., and Mitsubishi Tanaba Pharma Corp. over injuries allegedly caused by the drug. The Invokana lawsuit seeks more than $75,000 in compensation and alleges a number of claims including product liability, defective... Read More

One of the newer generations of diabetes medications, Invokana, has come under fire in recent months for potentially increasing the risk of serious health problems. Now, the FDA has issued a new safety communication informing healthcare practitioners and patients that the agency has revised labeling information... Read More